Phthalic Acid

Phthalic Acid

SCHEMBL533819

N.N.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL533818 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL234376 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL7167306 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28266179 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28132941 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29037477 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29037475 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL146125 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL1686043 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4452470 0.97 ALDH1A1 (1.00) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 594 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024128210-A1 COMPOSITION FOR PHOTORESIST REMOVAL AND METHOD FOR REMOVING PHOTORESIST 三菱瓦斯化学株式会社 2024-06-20 WO claimed
CN-107698577-B Benzimidazole derivative, preparation method thereof and application thereof in tumor resistance 广东工业大学 2020-08-11 CN claimed
WO-2019196132-A1 PENTANEDIAMINE SEBACATE SALT AND CRYSTAL THEREOF 南京工业大学 2019-10-17 WO claimed
EP-1838657-B1 METHOD TO PRODUCE A CARBOXYLIC ACID ESTER FROM A CARBOXYLIC ACID AMMONIUM SALT BY ALCOHOLYSIS DU PONT (US) 2010-11-17 EP claimed
US-7528277-B2 Method to produce a carboxylic acid ester from a carboxylic acid ammonium salt by alcoholysis E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-05-05 US claimed
EP-1838657-A2 METHOD TO PRODUCE A CARBOXYLIC ACID ESTER FROM A CARBOXYLIC ACID AMMONIUM SALT BY ALCOHOLYSIS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2007-10-03 EP claimed
US-20060189821-A1 Method to produce a carboxylic acid ester from a carboxylic acid ammonium salt by alcoholysis PURETECH SCIENTIFIC LLC 2006-08-24 US claimed
WO-2006069113-A2 METHOD TO PRODUCE A CARBOXYLIC ACID ESTER FROM A CARBOXYLIC ACID AMMONIUM SALT BY ALCOHOLYSIS E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-06-29 WO claimed
EP-0970156-B1 CHEMICAL-MECHANICAL POLISHING SLURRY FORMULATION AND METHOD FOR TUNGSTEN AND TITANIUM THIN FILMS ADVANCED MICRO DEVICES INC (US) 2003-09-24 EP claimed
US-5916855-A ABRASIVE PARTICLES HAVING SOLUBILITY COATING COMPRISING PHTHALATE-CONTAINING COMPOUND, FERRIC SALT OXIDIZER, SUSPENSION AGENT, TITANIUM OXIDIER ADVANCED MICRO DEVICES, INC. (US) 1999-06-29 US claimed
WO-1998042790-A1 CHEMICAL-MECHANICAL POLISHING SLURRY FORMULATION AND METHOD FOR TUNGSTEN AND TITANIUM THIN FILMS ADVANCED MICRO DEVICES, INC. (US) 1998-10-01 WO claimed
US-4118391-A Process for the preparation of copper phthalolcyanine BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 US claimed
JP-56050902-A None JP disclosed
US-20250011294-A1 METHOD FOR PRODUCING COMPOUND MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-01-09 US disclosed
EP-4400496-A1 METHOD FOR PRODUCING COMPOUND MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-07-17 EP disclosed
WO-2024128210-A1 COMPOSITION FOR PHOTORESIST REMOVAL AND METHOD FOR REMOVING PHOTORESIST 三菱瓦斯化学株式会社 2024-06-20 WO disclosed
US-4118391-A Process for the preparation of copper phthalolcyanine BAYER AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed
US-4102892-A Process for the preparation of copper phthylocyanine BAYER AKTIENGESELLSCHAFT (DE) 1978-07-25 US disclosed
US-4077972-A Process for the preparation and conditioning of copper phthalocyanine BAYER AKTIENGESELLSCHAFT (DT) 1978-03-07 US disclosed
US-4001273-A CONTINUOUS MANUFACTURE OF PHTHALIMIDE BASF AKTIENGESELLSCHAFT (DT) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011294-A1 METHOD FOR PRODUCING COMPOUND HMOX2, HMOX1, DAO ALDH1A1 663/4885ALOX15 43/4885AKR1C3 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.